Report Detail
Global PARKINSON'S DISEASE DRUG Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
- RnM4140881 |
- 18 August, 2020 |
- Global |
- 112 Pages |
- XYZResearch |
- Pharma & Healthcare
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global PARKINSON'S DISEASE DRUG market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of PARKINSON'S DISEASE DRUG Market by XYZResearch Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in PARKINSON'S DISEASE DRUG Market?
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Valeant Pharmaceuticals
...
Major Type of PARKINSON'S DISEASE DRUG Covered in XYZResearch report:
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Others
Application Segments Covered in XYZResearch Market
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global PARKINSON'S DISEASE DRUG Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
- 1.1 Product Details and Introduction
- 1.1.1 Sinemet-CR -Product Introduction and Major Manufacturers
- 1.1.2 Trastal -Product Introduction and Major Manufacturers
- 1.1.3 Madopar -Product Introduction and Major Manufacturers
- 1.1.4 COMT Inhibitor -Product Introduction and Major Manufacturers
- 1.1.5 Others -Product Introduction and Major Manufacturers
- 1.2 Market Snapshot
- 1.2.1 Major Companies Overview
- 1.2.2 Market Concentration
- 1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
- 2.1 China PARKINSON'S DISEASE DRUG Status and Prospect (2015-2026)
- 2.1.1 China PARKINSON'S DISEASE DRUG Market Size and Growth Rate (2015-2026)
- 2.1.2 China PARKINSON'S DISEASE DRUG Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
- 2.2 EU PARKINSON'S DISEASE DRUG Status and Prospect (2015-2026)
- 2.2.1 EU PARKINSON'S DISEASE DRUG Market Size and Growth Rate (2015-2026)
- 2.2.2 EU PARKINSON'S DISEASE DRUG Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
- 2.3 USA PARKINSON'S DISEASE DRUG Status and Prospect (2015-2026)
- 2.3.1 USA PARKINSON'S DISEASE DRUG Market Size and Growth Rate (2015-2026)
- 2.3.2 USA PARKINSON'S DISEASE DRUG Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
- 2.4 Japan PARKINSON'S DISEASE DRUG Status and Prospect (2015-2026)
- 2.4.1 Japan PARKINSON'S DISEASE DRUG Market Size and Growth Rate (2015-2026)
- 2.4.2 Japan PARKINSON'S DISEASE DRUG Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
- 2.5 India PARKINSON'S DISEASE DRUG Status and Prospect (2015-2026)
- 2.5.1 India PARKINSON'S DISEASE DRUG Market Size and Growth Rate (2015-2026)
- 2.5.2 India PARKINSON'S DISEASE DRUG Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
- 2.6 Southeast Asia PARKINSON'S DISEASE DRUG Status and Prospect (2015-2026)
- 2.6.1 Southeast Asia PARKINSON'S DISEASE DRUG Market Size and Growth Rate (2015-2026)
- 2.6.2 Southeast Asia PARKINSON'S DISEASE DRUG Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
- 2.7 South America PARKINSON'S DISEASE DRUG Status and Prospect (2015-2026)
- 2.7.1 South America PARKINSON'S DISEASE DRUG Market Size and Growth Rate (2015-2026)
- 2.7.2 South America PARKINSON'S DISEASE DRUG Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
- 2.8 PARKINSON'S DISEASE DRUG Status and Prospect (2015-2026)
- 2.8.1 PARKINSON'S DISEASE DRUG Market Size and Growth Rate (2015-2026)
- 2.8.2 PARKINSON'S DISEASE DRUG Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global PARKINSON'S DISEASE DRUG Market Assessment by Segment
- 3.1 Global PARKINSON'S DISEASE DRUG Capacity and Growth Rate
- 3.2 Global PARKINSON'S DISEASE DRUG Sales by Type
- 3.3 Global PARKINSON'S DISEASE DRUG Sales Revenue by Type
- 3.4 Global PARKINSON'S DISEASE DRUG Consumption by Application
4 Global PARKINSON'S DISEASE DRUG Market Assessment by Regions
- 4.1 Global PARKINSON'S DISEASE DRUG Production Analysis and Forecast by Regions (2015-2026)
- 4.2 Global PARKINSON'S DISEASE DRUG Sales Analysis and Forecast by Regions (2015-2026)
- 4.3 Global PARKINSON'S DISEASE DRUG Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
- 5.1 PARKINSON'S DISEASE DRUG Value Chain Analysis
- 5.1.1 Upstream
- 5.1.2 Downstream
- 5.2 COVID-19 Impact on PARKINSON'S DISEASE DRUG Industry
- 5.2.1 Industrial Policy Issued Under the Epidemic Situation
- 5.3 Cost-Under the Epidemic Situation
- 5.3.1 Cost of Raw Material
- 5.4 Channel Analysis
- 5.4.1 Distribution Channel-Under the Epidemic Situation
- 5.4.2 Distributors
6 Competitive Landscape
- 6.1 Global PARKINSON'S DISEASE DRUG Capacity Market Share of Manufacturers (2019-2020)
- 6.2 Global PARKINSON'S DISEASE DRUG Sales Market Share of Manufacturers (2019-2020)
- 6.3 Global PARKINSON'S DISEASE DRUG Sales Revenue Market Share of Manufacturers (2019-2020)
7 PARKINSON'S DISEASE DRUG Competitive Analysis
- 7.1 Merck
- 7.1.1 Merck Company Profile
- 7.1.2 Merck Product Introduction
- 7.1.3 Merck PARKINSON'S DISEASE DRUG Capacity, Sales, Revenue, Price and Gross Margin
- 7.1.4 SWOT Analysis
- 7.2 Akorn
- 7.2.1 Akorn Company Profile
- 7.2.2 Akorn Product Introduction
- 7.2.3 Akorn PARKINSON'S DISEASE DRUG Capacity, Sales, Revenue, Price and Gross Margin (2015-2020)
- 7.2.4 SWOT Analysis
- 7.3 GSK
- 7.3.1 GSK Company Profile
- 7.3.2 GSK Product Introduction
- 7.3.3 GSK PARKINSON'S DISEASE DRUG Capacity, Sales, Revenue, Price and Gross Margin
- 7.3.4 SWOT Analysis
- 7.4 Novartis
- 7.4.1 Novartis Company Profile
- 7.4.2 Novartis Product Introduction
- 7.4.3 Novartis PARKINSON'S DISEASE DRUG Capacity, Sales, Revenue, Price and Gross Margin
- 7.4.4 SWOT Analysis
- 7.5 Boehringer Ingelheim
- 7.5.1 Boehringer Ingelheim Company Profile
- 7.5.2 Boehringer Ingelheim Product Introduction
- 7.5.3 Boehringer Ingelheim PARKINSON'S DISEASE DRUG Capacity, Sales, Revenue, Price and Gross Margin
- 7.5.4 SWOT Analysis
- 7.6 Teva Pharmaceutical
- 7.6.1 Teva Pharmaceutical Company Profile
- 7.6.2 Teva Pharmaceutical Product Introduction
- 7.6.3 Teva Pharmaceutical PARKINSON'S DISEASE DRUG Capacity, Sales, Revenue, Price and Gross Margin
- 7.6.4 SWOT Analysis
- 7.7 Abbvie
- 7.7.1 Abbvie Company Profile
- 7.7.2 Abbvie Product Introduction
- 7.7.3 Abbvie PARKINSON'S DISEASE DRUG Capacity, Sales, Revenue, Price and Gross Margin
- 7.7.4 SWOT Analysis
- 7.8 Kyowa Hakko Kirin Pharma
- 7.8.1 Kyowa Hakko Kirin Pharma Company Profile
- 7.8.2 Kyowa Hakko Kirin Pharma Product Introduction
- 7.8.3 Kyowa Hakko Kirin Pharma PARKINSON'S DISEASE DRUG Capacity, Sales, Revenue, Price and Gross Margin
- 7.8.4 SWOT Analysis
- 7.9 Astellas Pharma
- 7.9.1 Astellas Pharma Company Profile
- 7.9.2 Astellas Pharma Product Introduction
- 7.9.3 Astellas Pharma PARKINSON'S DISEASE DRUG Capacity, Sales, Revenue, Price and Gross Margin
- 7.9.4 SWOT Analysis
- 7.10 Desitin Arzneimittel
- 7.10.1 Desitin Arzneimittel Company Profile
- 7.10.2 Desitin Arzneimittel Product Introduction
- 7.10.3 Desitin Arzneimittel PARKINSON'S DISEASE DRUG Capacity, Sales, Revenue, Price and Gross Margin
- 7.10.4 SWOT Analysis
- 7.11 Endo Pharmaceuticals
- 7.12 F.Hoffmann-La Roche
- 7.13 H.Lundbeck
- 7.14 Valeant
- 7.15 Apokyn
- 7.16 Orion
- 7.17 Stada Arzneimittel
- 7.18 US WorldMeds
- 7.19 Valeant Pharmaceuticals
8 Conclusion
Summary:
Get latest Market Research Reports on PARKINSON'S DISEASE DRUG. Industry analysis & Market Report on PARKINSON'S DISEASE DRUG is a syndicated market report, published as Global PARKINSON'S DISEASE DRUG Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin. It is complete Research Study and Industry Analysis of PARKINSON'S DISEASE DRUG market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
